Researchers at the University of Exeter and clinical radiopharmaceutical company Serac Healthcare Ltd are researching a new molecular imaging marker which could help to detect disease progression ...
New-onset interstitial lung disease can be detected up to 10 years after initial negative screening in patients with systemic sclerosis, with a higher mortality risk vs those without lung involvement.
According to a new study, the score can accurately predict long-term outcomes in patients with IPF and ILD associated with connective tissue disease.
Slower oxygen recovery after a 6-minute walk test may predict poorer lung function and a higher risk for disease progression in patients with fibrotic interstitial lung disease.
RILD in NHL patients presents as lung disease, organizing pneumonia, and nonspecific interstitial pneumonia, with 179 pathogenic microorganisms identified. The study systematically characterized RILD ...
The ATS/ERS 2025 statement on interstitial pneumonia classification updates the 2013 statement, with insights on secondary ...
Zongertinib Shows Durable Responses With No Interstitial Lung Disease in HER2-Mutated Advanced NSCLC
Zongertinib showed a 71% overall response rate and 93% disease control rate in HER2-mutated NSCLC patients, with a median PFS of 12.4 months. No cases of interstitial lung disease were reported, even ...
WHAT IS INTERSTITIAL LUNG DISEASE? Overview of Interstitial Lung Disease (ILD):Interstitial Lung Disease refers to a group of lung conditions that cause inflammation and scarring of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results